Literature DB >> 33369626

The Pharmacologic Treatment of Schizophrenia-2021.

Donald C Goff1,2.   

Abstract

Entities:  

Year:  2020        PMID： 33369626     DOI： 10.1001/jama.2020.19048

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  10 in total

Review 1.  New Paradigms of Old Psychedelics in Schizophrenia.

Authors:  Danish Mahmood; Sattam K Alenezi; Md Jamir Anwar; Faizul Azam; Kamal A Qureshi; Mariusz Jaremko
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-23

2.  Histamine H1 Receptor in Basal Forebrain Cholinergic Circuit: A Novel Target for the Negative Symptoms of Schizophrenia?

Authors:  Shuangshuang Wu; Chenshu Gao; Feng Han; Heming Cheng
Journal:  Neurosci Bull       Date:  2021-12-27       Impact factor: 5.203

3.  Cadence discovery: study protocol for a dose-finding and mechanism of action clinical trial of sodium benzoate in people with treatment-refractory schizophrenia.

Authors:  Andrea Baker; Lachlan Clarke; Peter Donovan; Jacobus P J Ungerer; Gunter Hartel; George Bruxner; Luca Cocchi; Anne Gordon; Vikas Moudgil; Gail Robinson; Digant Roy; Ravinder Sohal; Emma Whittle; James G Scott
Journal:  Trials       Date:  2021-12-13       Impact factor: 2.279

4.  Gait Alterations in the Prediction of Metabolic Syndrome in Patients With Schizophrenia: A Pilot Study With PODOSmart ® Insoles.

Authors:  Dimitris Efthymiou; Dimitrios X Zekakos; Evangelia Papatriantafyllou; Efthimis Ziagkas; Alexandros N Petrelis; Emilia Vassilopoulou
Journal:  Front Psychiatry       Date:  2022-01-27       Impact factor: 4.157

5.  CYP2D6 Gene Polymorphisms and Variable Metabolic Activity in Schizophrenia Patients of Han and Tibetan Populations.

Authors:  Yong-Hang Li; Wei Huang; Man-Yu Xiao; Shi-Qing Huang; Hui Chen; Zai-Fang Li; Xue-Song Li; Yong Cheng
Journal:  Neuropsychiatr Dis Treat       Date:  2022-04-02       Impact factor: 2.570

6.  Abnormalities of Electroencephalography Microstates in Drug-Naïve, First-Episode Schizophrenia.

Authors:  Qiaoling Sun; Linlin Zhao; Liwen Tan
Journal:  Front Psychiatry       Date:  2022-03-14       Impact factor: 4.157

7.  DHF-7 Ameliorates Behavioral Disorders and White Matter Lesions by Regulating BDNF and Fyn in a Mouse Model of Schizophrenia Induced by Cuprizone and MK-801.

Authors:  Zheng-Yu Sun; Deng-Lei Ma; Li-Hong Gu; Xi Chen; Lan Zhang; Lin Li
Journal:  Int J Neuropsychopharmacol       Date:  2022-08-04       Impact factor: 5.678

8.  10-Year Trends in Healthcare Spending among Patients with Schizophrenia in Alberta, Canada.

Authors:  Andrew J Stewart; Scott B Patten; Kirsten M Fiest; Tyler S Williamson; James P Wick; Paul E Ronksley
Journal:  Can J Psychiatry       Date:  2022-03-04       Impact factor: 5.321

Review 9.  The Effects of Antipsychotic Treatment on the Brain of Patients With First-Episode Schizophrenia: A Selective Review of Longitudinal MRI Studies.

Authors:  Chengmin Yang; Jing Tang; Naici Liu; Li Yao; Mengyuan Xu; Hui Sun; Bo Tao; Qiyong Gong; Hengyi Cao; Wenjing Zhang; Su Lui
Journal:  Front Psychiatry       Date:  2021-06-24       Impact factor: 4.157

10.  Barriers and Enablers to Shared Decision Making in Psychiatric Medication Management: A Qualitative Investigation of Clinician and Service Users' Views.

Authors:  Emma Kaminskiy; Yaara Zisman-Ilani; Nicola Morant; Shulamit Ramon
Journal:  Front Psychiatry       Date:  2021-06-17       Impact factor: 4.157
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.